Geppetti P - Search Results

1

Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients.

Degli Esposti L, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bari M, Marchionni N, Sturani A, Buda S, Degli Esposti E. Degli Esposti L, et al. Among authors: geppetti p. Clinicoecon Outcomes Res. 2011;3:47-54. doi: 10.2147/CEOR.S15619. Epub 2011 Mar 7. Clinicoecon Outcomes Res. 2011. PMID: 21935332 Free PMC article.

2

Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.

Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, Sturani A, Buda S, Degli Esposti E. Degli Esposti L, et al. Among authors: geppetti p. Clin Ther. 2012 Jan;34(1):190-9. doi: 10.1016/j.clinthera.2011.12.011. Clin Ther. 2012. PMID: 22284998

3

Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years.

Degli Esposti L, Saragoni S, Batacchi P, Geppetti P, Buda S, Degli Esposti E. Degli Esposti L, et al. Among authors: geppetti p. Clinicoecon Outcomes Res. 2010;2:113-20. doi: 10.2147/ceor.s11933. Epub 2010 Jul 28. Clinicoecon Outcomes Res. 2010. PMID: 21935320 Free PMC article.

4

Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.

De Giorgi V, Gandini S, Grazzini M, Benemei S, Marchionni N, Geppetti P. De Giorgi V, et al. Among authors: geppetti p. Mayo Clin Proc. 2013 Nov;88(11):1196-203. doi: 10.1016/j.mayocp.2013.09.001. Mayo Clin Proc. 2013. PMID: 24182700

5

Treatment with β-blockers and reduced disease progression in patients with thick melanoma.

De Giorgi V, Grazzini M, Gandini S, Benemei S, Lotti T, Marchionni N, Geppetti P. De Giorgi V, et al. Among authors: geppetti p. Arch Intern Med. 2011 Apr 25;171(8):779-81. doi: 10.1001/archinternmed.2011.131. Arch Intern Med. 2011. PMID: 21518948

6

In reply--Effect of β-adrenergic blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.

De Giorgi V, Gandini S, Grazzini M, Benemei S, Marchionni N, Geppetti P. De Giorgi V, et al. Among authors: geppetti p. Mayo Clin Proc. 2014 Aug;89(8):1167-8. doi: 10.1016/j.mayocp.2014.06.003. Mayo Clin Proc. 2014. PMID: 25092368 No abstract available.

7

β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up.

De Giorgi V, Grazzini M, Benemei S, Marchionni N, Geppetti P, Gandini S. De Giorgi V, et al. Among authors: geppetti p. Melanoma Res. 2017 Jun;27(3):268-270. doi: 10.1097/CMR.0000000000000317. Melanoma Res. 2017. PMID: 28346289

8

Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose.

Geppetti P, Benemei S. Geppetti P, et al. Clin Drug Investig. 2009;29 Suppl 1:3-16. doi: 10.2165/0044011-200929001-00002. Clin Drug Investig. 2009. PMID: 19445550 Review.

9

β-adrenergic-blocking drugs and melanoma: current state of the art.

De Giorgi V, Grazzini M, Gandini S, Benemei S, Asbury CD, Marchionni N, Geppetti P. De Giorgi V, et al. Among authors: geppetti p. Expert Rev Anticancer Ther. 2012 Nov;12(11):1461-7. doi: 10.1586/era.12.118. Expert Rev Anticancer Ther. 2012. PMID: 23249110 Review.

10

Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study.

De Giorgi V, Grazzini M, Benemei S, Marchionni N, Botteri E, Pennacchioli E, Geppetti P, Gandini S. De Giorgi V, et al. Among authors: geppetti p. JAMA Oncol. 2018 Feb 8;4(2):e172908. doi: 10.1001/jamaoncol.2017.2908. Epub 2018 Feb 8. JAMA Oncol. 2018. PMID: 28973254 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters